GEPPX
Price
$10.33
Change
-$0.03 (-0.29%)
Updated
Sep 20 closing price
VEIEX
Price
$28.70
Change
-$0.11 (-0.38%)
Updated
Sep 20 closing price
Ad is loading...

GEPPX vs VEIEX

Header iconGEPPX vs VEIEX Comparison
Open Charts GEPPX vs VEIEXBanner chart's image
Goldman Sachs ESG Em Mkts Eq P
Price$10.33
Change-$0.03 (-0.29%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$28.70
Change-$0.11 (-0.38%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GEPPX vs VEIEX Comparison Chart
Loading...
VS
GEPPX vs. VEIEX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEPPX is a StrongBuy and VEIEX is a Sell.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 108B vs. GEPPX (23M). VEIEX pays higher dividends than GEPPX: VEIEX (3.27) vs GEPPX (1.56). GEPPX was incepted earlier than VEIEX: GEPPX (5 years) vs VEIEX (30 years). GEPPX is a more actively managed with annual turnover of: 54.00 vs. VEIEX (5.00). GEPPX (0) and VEIEX (0) have matching initial minimum investment requirements. GEPPX annual gain was more profitable for investors over the last year : 21.35 vs. VEIEX (17.66).
GEPPXVEIEXGEPPX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years30 years-
Gain YTD14.22310.765132%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets23M108B0%
Annual Yield % from dividends1.563.2748%
Returns for 1 year21.3517.66121%
Returns for 3 years-24.58-3.65674%
Returns for 5 yearsN/A19.16-
Returns for 10 yearsN/A23.13-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHKP194.093.00
+1.57%
Check Point Software Technologies Ltd
KFY74.81-0.80
-1.06%
Korn Ferry
MGIH1.66-0.02
-1.19%
Millennium Group International Holdings Limited
DXPE52.79-1.10
-2.04%
DXP Enterprises
ATAI1.22-0.04
-3.17%
ATAI Life Sciences NV